Liothyronine Sodium
- Product NDC
- 43063-884
- 11-digit product format
- 430630884
- Labeler code
- 43063
- Product ID
- 43063-884_415c6ae0-9636-3fb9-e063-6394a90accdc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Liothyronine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA200295
- Marketing category
- ANDA
- Marketing start
- 2012-12-03
- Substance
- LIOTHYRONINE SODIUM
- Active strength
- 25 ug/1
- Pharmacologic classes
- Triiodothyronine [CS], l-Triiodothyronine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Liothyronine Sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LIOTHYRONINE SODIUM | 25 ug/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | GCA9VV7D2N |
| Rxcui | 903697 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43063-884-30 | Liothyronine Sodium | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 16 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43063-884 | LIOTHYRONINE SODIUM TABLET [PD-RX PHARMACEUTICALS, INC.] | 15 | Current NDC, Legacy NDC, 1 package rows | 20241018_76fa4eb6-fefa-4e97-9543-f81e465743e6.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43063-884-30 | 43063088430 | 30 TABLET in 1 BOTTLE, PLASTIC (43063-884-30) | 30 tablet | 2018-08-16 | 0000-00-00 | No | No | Current |